VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 140 filers reported holding VERASTEM INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $60,304 | -6.3% | 145,241 | -9.2% | 0.00% | – |
| Q4 2022 | $64,357 | -61.5% | 159,894 | -18.4% | 0.00% | – |
| Q3 2022 | $167,000 | -51.5% | 196,051 | -33.8% | 0.00% | – |
| Q2 2022 | $344,000 | -17.1% | 296,134 | +0.5% | 0.00% | – |
| Q1 2022 | $415,000 | -18.0% | 294,561 | +19.6% | 0.00% | – |
| Q4 2021 | $506,000 | -14.1% | 246,312 | +28.7% | 0.00% | – |
| Q3 2021 | $589,000 | -9.9% | 191,419 | +19.0% | 0.00% | – |
| Q2 2021 | $654,000 | +588.4% | 160,809 | +316.5% | 0.00% | – |
| Q1 2021 | $95,000 | -71.1% | 38,614 | -75.0% | 0.00% | – |
| Q4 2020 | $329,000 | +457.6% | 154,480 | +217.1% | 0.00% | – |
| Q3 2020 | $59,000 | -94.3% | 48,713 | -91.9% | 0.00% | – |
| Q2 2020 | $1,030,000 | +1371.4% | 598,224 | +2147.3% | 0.00% | – |
| Q1 2020 | $70,000 | -64.3% | 26,620 | -81.9% | 0.00% | – |
| Q4 2019 | $196,000 | -6.7% | 147,142 | -14.9% | 0.00% | – |
| Q3 2019 | $210,000 | -70.3% | 172,991 | -63.0% | 0.00% | – |
| Q2 2019 | $706,000 | +40.4% | 467,873 | +175.1% | 0.00% | – |
| Q1 2019 | $503,000 | -90.7% | 170,095 | -89.4% | 0.00% | -100.0% |
| Q4 2018 | $5,406,000 | +279.6% | 1,608,818 | +719.4% | 0.00% | – |
| Q3 2018 | $1,424,000 | +17.9% | 196,349 | +11.8% | 0.00% | – |
| Q2 2018 | $1,208,000 | +1355.4% | 175,658 | +534.1% | 0.00% | – |
| Q1 2018 | $83,000 | +453.3% | 27,701 | +472.6% | 0.00% | – |
| Q4 2017 | $15,000 | -42.3% | 4,838 | -12.6% | 0.00% | – |
| Q3 2017 | $26,000 | +23.8% | 5,538 | -43.6% | 0.00% | – |
| Q2 2017 | $21,000 | +50.0% | 9,815 | +63.7% | 0.00% | – |
| Q1 2017 | $14,000 | -83.3% | 5,994 | -92.0% | 0.00% | – |
| Q4 2016 | $84,000 | +460.0% | 74,666 | +554.7% | 0.00% | – |
| Q3 2016 | $15,000 | -31.8% | 11,405 | -34.4% | 0.00% | – |
| Q2 2016 | $22,000 | -33.3% | 17,383 | -14.1% | 0.00% | – |
| Q1 2016 | $33,000 | +200.0% | 20,225 | +225.2% | 0.00% | – |
| Q4 2015 | $11,000 | +83.3% | 6,219 | +72.2% | 0.00% | – |
| Q3 2015 | $6,000 | -97.7% | 3,611 | -89.5% | 0.00% | – |
| Q2 2015 | $259,000 | +28.9% | 34,299 | +73.6% | 0.00% | – |
| Q1 2015 | $201,000 | -26.1% | 19,758 | -33.8% | 0.00% | – |
| Q4 2014 | $272,000 | +28.3% | 29,836 | +19.6% | 0.00% | – |
| Q3 2014 | $212,000 | -6.2% | 24,949 | -0.2% | 0.00% | – |
| Q2 2014 | $226,000 | -7.4% | 25,007 | +10.4% | 0.00% | – |
| Q1 2014 | $244,000 | -30.1% | 22,657 | -26.0% | 0.00% | – |
| Q4 2013 | $349,000 | -62.2% | 30,608 | -58.7% | 0.00% | – |
| Q3 2013 | $924,000 | +233.6% | 74,175 | +272.0% | 0.00% | – |
| Q2 2013 | $277,000 | – | 19,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |